IMCR
Income statement / Annual
Last year (2025), Immunocore Holdings plc's total revenue was $297.57 M,
an increase of 20.00% from the previous year.
In 2025, Immunocore Holdings plc's net income was -$26.42 M.
See Immunocore Holdings plc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$297.57 M |
$247.98 M |
$197.39 M |
$144.23 M |
$27.04 M |
$30.11 M |
$25.67 M |
$23.65 M |
$19.17 M |
$20.21 M |
| Cost of Revenue |
$6.21 M
|
$5.54 M
|
$820.63 K
|
$5.29 M
|
$0.00
|
$74.81 M
|
$99.99 M
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$291.36 M
|
$242.44 M
|
$196.57 M
|
$138.94 M
|
$27.04 M
|
-$44.70 M
|
-$74.32 M
|
$23.65 M
|
$19.17 M
|
$20.21 M
|
| Gross Profit Ratio |
0.98
|
0.98
|
1
|
0.96
|
1
|
-1.48
|
-2.9
|
1
|
1
|
1
|
| Research and Development Expenses |
$204.47 M
|
$177.44 M
|
$129.42 M
|
$84.31 M
|
$74.31 M
|
$74.81 M
|
$99.99 M
|
$83.58 M
|
$81.13 M
|
$56.50 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$45.74 M
|
$44.18 M
|
$34.16 M
|
$29.22 M
|
$4.60 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$120.62 M
|
$121.17 M
|
$114.35 M
|
$0.00
|
$82.15 M
|
$45.74 M
|
$44.18 M
|
$34.16 M
|
$29.22 M
|
$4.60 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$97.40 M
|
$0.00
|
-$79.05 M
|
-$100.18 M
|
$0.00
|
-$411.37 K
|
-$1.01 M
|
| Operating Expenses |
$325.09 M
|
$298.77 M
|
$243.77 M
|
$181.71 M
|
$156.46 M
|
$41.50 M
|
$44.00 M
|
$117.73 M
|
$109.94 M
|
$60.09 M
|
| Cost And Expenses |
$331.31 M
|
$304.31 M
|
$244.59 M
|
$187.01 M
|
$156.46 M
|
$116.31 M
|
$143.99 M
|
$117.11 M
|
$109.94 M
|
$60.09 M
|
| Interest Income |
$16.48 M
|
$25.62 M
|
$14.23 M
|
$3.76 M
|
$65.00 K
|
$706.00 K
|
$1.40 M
|
$822.00 K
|
$0.00
|
$0.00
|
| Interest Expense |
$12.17 M
|
$18.84 M
|
$4.08 M
|
$5.41 M
|
$5.57 M
|
$3.11 M
|
$3.80 M
|
$842.00 K
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$2.43 M
|
$3.36 M
|
$3.24 M
|
$4.41 M
|
$5.63 M
|
$6.45 M
|
$6.76 M
|
$6.71 M
|
$5.25 M
|
$3.30 M
|
| EBITDA |
$387.18 K |
-$38.50 M |
-$40.87 M |
-$38.35 M |
-$123.58 M |
-$82.38 M |
-$111.56 M |
-$86.75 M |
-$85.53 M |
-$36.57 M |
| EBITDA Ratio |
0
|
-0.16
|
-0.21
|
-0.27
|
-4.57
|
-2.74
|
-4.35
|
-3.67
|
-4.46
|
-1.81
|
| Operating Income Ratio |
-0.11
|
-0.23
|
-0.24
|
-0.3
|
-4.79
|
-2.86
|
-4.61
|
-3.95
|
-4.74
|
-1.97
|
| Total Other Income/Expenses Net |
$19.53 M
|
$14.01 M
|
-$982.07 K
|
$8.95 M
|
-$3.92 M
|
-$1.17 M
|
$36.65 M
|
$5.28 M
|
$3.76 M
|
$1.55 M
|
| Income Before Tax |
-$14.21 M
|
-$42.32 M
|
-$48.19 M
|
-$33.82 M
|
-$133.34 M
|
-$87.36 M
|
-$81.67 M
|
-$88.18 M
|
-$87.02 M
|
-$38.32 M
|
| Income Before Tax Ratio |
-0.05
|
-0.17
|
-0.24
|
-0.23
|
-4.93
|
-2.9
|
-3.18
|
-3.73
|
-4.54
|
-1.9
|
| Income Tax Expense |
$12.21 M
|
-$1.48 M
|
-$4.43 M
|
$9.65 M
|
$111.19 K
|
-$13.27 M
|
$22.26 M
|
-$16.55 M
|
$21.26 M
|
$9.92 M
|
| Net Income |
-$26.42 M
|
-$40.81 M
|
-$43.75 M
|
-$43.46 M
|
-$133.45 M
|
-$74.09 M
|
-$103.93 M
|
-$71.63 M
|
-$65.76 M
|
-$28.40 M
|
| Net Income Ratio |
-0.09
|
-0.16
|
-0.22
|
-0.3
|
-4.93
|
-2.46
|
-4.05
|
-3.03
|
-3.43
|
-1.41
|
| EPS |
-0.53 |
-1.02 |
-0.89 |
-0.95 |
-3.13 |
-2.33 |
-3.81 |
-2.62 |
-26.74 |
-11.6 |
| EPS Diluted |
-0.53 |
-1.02 |
-0.89 |
-0.95 |
-3 |
-2.33 |
-3.81 |
-2.62 |
-26.74 |
-11.6 |
| Weighted Average Shares Out |
$50.35 M
|
$49.99 M
|
$48.89 M
|
$45.71 M
|
$42.49 M
|
$31.78 M
|
$27.31 M
|
$27.31 M
|
$2.46 M
|
$2.45 M
|
| Weighted Average Shares Out Diluted |
$50.35 M
|
$49.99 M
|
$48.89 M
|
$45.71 M
|
$43.86 M
|
$31.78 M
|
$27.31 M
|
$27.31 M
|
$2.46 M
|
$2.45 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
